• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Voice Preservation

Making Our Voices Heard

Speech is a key part of a person’s identity. Voice matters to personal identity and expression, and connection with family and friends. The majority of people living with ALS/MND are eventually robbed of this fundamental part of their humanity.

This can be overcome using voice preservation technologies, but our research shows this is not equitably accessible. The Alliance seeks to provide universal access to technology to improve the quality of life of people living with ALS/MND. The ideal for every individual living with ALS/MND worldwide is to have the right to access voice preservation upon diagnosis.

The Voice Preservation Project

The Alliance, through a collaboration between Hospital Universitario Nacional de Colombia (HUN) and the Asociación Colombiana de ELA (ACELA), has launched a pilot project to deliver voice preservation technology to people living with ALS/MND in Colombia. This will serve as the basis on which future plans will be made on how best to scale to reach more people around the world.

If you would like to join us in expanding our reach to more people, please donate. We deeply appreciate your support.

Watch this video to find out more from the Alliance and its Information Technology Advisory Council (ITAC).

https://www.als-mnd.org/wp-content/uploads/2023/06/Voice-Preservation-ITAC-Intro.mp4

Watch this video to hear from Orlando Ruiz, founder of ACELA and a person living with ALS/MND, as he emphasizes the devastation of losing your voice. He goes on to explain the potential of voice banking technology to preserve dignity, autonomy and identity, and ensure no one loses their voice to ALS/MND.

 

Keep Up To Date

This project is in development and more details and information are coming soon! If you are interested in learning more, sign up to get periodic updates as the work progresses.

Subscribe

* indicates required
 
 

 

Disclaimer: Voice preservation is not designed, intended or made available for diagnosis, treatment or prevention of diseases or for use as a medical device. It is also not designed or intended to replace or be a substitute for professional medical advice, diagnosis, treatment or judgment.

Primary Sidebar

  • Ian Gale, Australia

    Ian Gale, Australia

  • Joanne Pratt, Australia

    Joanne Pratt, Australia

  • Tso-Ta Huang, Taiwan

    Tso-Ta Huang, Taiwan

  • Carlos Gomez Matallanas, Spain

    Carlos Gomez Matallanas, Spain

  • Marcelo Farinelli, Brazil

    Marcelo Farinelli, Brazil

  • Francisco Perez Palop, Spain

    Francisco Perez Palop, Spain

  • Cassio Fernando da Silva, Brazil

    Cassio Fernando da Silva, Brazil

  • Liam Dwyer, England

    Liam Dwyer, England

  • Mirca Bersani, Italy

    Mirca Bersani, Italy
    MircaBersani

  • Liam Dwyer, England

    Liam Dwyer, England

  • Steven Gallagher, Canada

    Steven Gallagher, Canada

  • Graham Johnson, Australia

    Graham Johnson, Australia

  • Anna Barrow, UK

    Anna Barrow, UK

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Xian-Zhang Niu, China

    Xian-Zhang Niu, China

  • Andres Estevez Guersznik, Ireland

    Andres Estevez Guersznik, Ireland

  • Colm Francis Davis, Ireland

    Colm Francis Davis, Ireland

  • Phil Rossall, UK

    Phil Rossall, UK

  • Juvenal Bayona Romero, Colombia

    Juvenal Bayona Romero, Colombia

  • Danny Reviers, Belgium

    Danny Reviers, Belgium

  • Anthony Lynch, Australia

    Anthony Lynch, Australia

  • Manuel Arn, Switzerland

    Manuel Arn, Switzerland

  • Dawn Morton, Scotland

    Dawn Morton, Scotland

  • Sam Hayden-Harler, UK

    Sam Hayden-Harler, UK

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • Glen Elison, USA

    Glen Elison, USA

  • Ian Roberts, Australia

    Ian Roberts, Australia

  • Paul Launer, USA

    Paul Launer, USA

  • Timmy, Belgium

    Timmy, Belgium

  • Liong Ting Ngu, Malaysia

    Liong Ting Ngu, Malaysia

  • Jason Goodman, USA

    Jason Goodman, USA

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Philip Brindle, England

    Philip Brindle, England

  • Leon Ryba, Argentina

    Leon Ryba, Argentina

  • Mark Miller, UK

    Mark Miller, UK

  • Dan Doctoroff, USA

    Dan Doctoroff, USA

  • Maria Santos Garcia Tellez, Mexico

    Maria Santos Garcia Tellez, Mexico

  • Olga Cosentino, Argentina

    Olga Cosentino, Argentina

  • Alberto Baez Murillo, Colombia

    Alberto Baez Murillo, Colombia

  • John Russo, USA

    John Russo, USA
    final3878

  • Rob Tison, USA

    Rob Tison, USA

  • Lucy Lintott, Scotland

    Lucy Lintott, Scotland

  • Roxana Canova, Argentina

    Roxana Canova, Argentina

  • Jan Zuring, Netherlands

    Jan Zuring, Netherlands

  • Marco Antonio Alvarez Mercado, Mexico

    Marco Antonio Alvarez Mercado, Mexico

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Ana Lilia Rodriguez, Mexico

    Ana Lilia Rodriguez, Mexico

  • Horacio Fritzer, Argentina

    Horacio Fritzer, Argentina

  • Claudia Cominetti, Italy

    Claudia Cominetti, Italy

  • Magdalena Ayala Rodríguez, Mexico

    Magdalena Ayala Rodríguez, Mexico

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login